EDITION OF FRI 25 SEP 2026
339 · HEALTH

Experimental Drug Reverses MS-Like Symptoms in Mice

publishers 4articles 4first reported 23 Sep, 18:00 UTCdeveloping since 24 Sep · 2 editions

An experimental drug reversed paralysis and vision loss in mice with an illness resembling multiple sclerosis, according to Medical Daily. Medical Xpress reported that an experimental drug reversed paralysis and vision loss in a multiple sclerosis model. Mirage News described the treatment as a modified HIV drug, while Medical Daily identified it as an experimental UVA drug.

The findings come from an animal model. Human clinical trials are still needed.

HOW THIS STORY WAS MADE

Written from 4 articles, headlines and summaries only; 4 independent newsrooms once syndicated copies count as one; the editor revised it.

Publishers
4
Source articles
4
Given to the writer
4, headlines and summaries only
Independent newsrooms
4
Second model (editor)
revised
Publication gate
passed
Human review
none

WHAT THE EDITOR DID

The second model checked the writer's draft against the same sources and changed it before publication. Struck words were in the draft; underlined words are its corrections.

WHAT IT FLAGGED editor revise: The story needed narrower attribution and removal of an unsourced safety/effectiveness claim. - "according to reports from Medical Xpress, Mirage News, Medical Daily and Inside Precision Medicine": The source material does not show that all four outlets reported the full claim about mice with an MS-like illness reversing paralysis and vision loss. - "do not establish that the treatment is safe or effective in people": The source material provided says human trials are still needed but does not specifically state that safety or effectiveness in people was not established.

THE DRAFT AND THE CHANGES

Experimental Drug Reverses MS-Like Symptoms in Mice

An experimental drug reversed paralysis and vision loss in mice with an illness resembling multiple sclerosis, according to reportsMedical fromDaily. Medical Xpress,Xpress Miragereported News,that Medicalan Dailyexperimental drug reversed paralysis and Insidevision Precisionloss Medicine.in a multiple sclerosis model. Mirage News described the treatment as a modified HIV drug, while Medical Daily identified it as an experimental UVA drug. The findings come from an animal model and do not establish that the treatment is safe or effective in people.model. Human clinical trials are still needed.

Written by a language model from the sources above, then checked by a second model that may only cut, attribute or correct. How it works →

OUTLETS CARRYING THE STORY, RUN BY RUN

0 2 4 25 Sep

WHAT HELD, WHAT CAME LATER

From the first reports to the latest

  • Nothing ran from the first third of the coverage to the last.

Entered the story later

  • Nothing new took hold after the first third.

HOW THIS STORY DEVELOPED: EVERY HEADLINE, EVERY OUTLET →